Vivo Capital
Latest statistics and disclosures from Vivo Capital's latest quarterly 13F-HR filing:
- Top 5 stock holdings are SLNO, VRNA, CDTX, TERN, TRVI, and represent 42.38% of Vivo Capital's stock portfolio.
- Added to shares of these 10 stocks: ABVX (+$31M), COGT (+$24M), SABS (+$23M), DYN (+$19M), DRUG (+$15M), DNTH (+$14M), Lb Pharmaceuticals (+$13M), CMPX (+$12M), CAMP (+$12M), PEPG (+$11M).
- Started 8 new stock positions in ABVX, EPRX, CAMP, MNPR, SABS, PEPG, DNTH, Lb Pharmaceuticals.
- Reduced shares in these 5 stocks: SLNO (-$114M), CMPS (-$9.4M), CTMX (-$9.2M), IOBT (-$8.6M), CELC (-$8.2M).
- Sold out of its positions in CELC, CMPS, IOBT.
- Vivo Capital was a net buyer of stock by $66M.
- Vivo Capital has $1.2B in assets under management (AUM), dropping by 27.18%.
- Central Index Key (CIK): 0001674712
Tip: Access up to 7 years of quarterly data
Positions held by Vivo Capital consolidated in one spreadsheet with up to 7 years of data
Download as csvPortfolio Holdings for Vivo Capital
Vivo Capital holds 47 positions in its portfolio as reported in the September 2025 quarterly 13F filing
Past Filings by Vivo Capital
SEC 13F filings are viewable for Vivo Capital going back to 2016
- Vivo Capital 2025 Q3 filed Nov. 14, 2025
- Vivo Capital 2025 Q2 filed Aug. 14, 2025
- Vivo Capital 2025 Q1 filed May 12, 2025
- Vivo Capital 2024 Q4 filed Feb. 13, 2025
- Vivo Capital 2024 Q3 filed Nov. 13, 2024
- Vivo Capital 2024 Q2 filed Aug. 14, 2024
- Vivo Capital 2024 Q1 filed April 22, 2024
- Vivo Capital 2023 Q4 filed Feb. 7, 2024
- Vivo Capital 2023 Q3 filed Nov. 8, 2023
- Vivo Capital 2023 Q2 filed Aug. 14, 2023
- Vivo Capital 2023 Q1 filed May 15, 2023
- Vivo Capital 2022 Q4 filed Feb. 13, 2023
- Vivo Capital 2022 Q3 filed Nov. 14, 2022
- Vivo Capital 2022 Q2 filed Aug. 15, 2022
- Vivo Capital 2022 Q1 filed May 13, 2022
- Vivo Capital 2021 Q4 filed Feb. 11, 2022